16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
For the past century, the City of Coral Gables has been known for the high quality of the original p...
Read More >
The current pandemic is having a serious impact on construction operations across the globe and our ...
Read More >
In 2021, we bring you an overview of European competition news. In collaboration with our European o...
Read More >
Recent headlines have detailed foreign-state actors targeting utilities and independent power produc...
Read More >
The long-awaited modernization of German securities law has begun! Two Germany ministries have joint...
Read More >
The recent novel coronavirus (COVID-19) outbreak has caused significant disruption to the global eco...
Read More >